Amicus Therapeutics Inc (FOLD)

EBITDA Margin

8.89%

Quarterly · Period ending:

FOLD logo

FOLD EBITDA Margin

Latest reported8.89%
FOLD Quarterly EBITDA Margin (0.00% → 8.89%)
High-resolution chart · PNG

FOLD ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Amicus Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
8.8914%
28.3087%
-3.7262%
-3.7948%
14.6507%
15.2964%
11.6856%
-26.2611%
-14.4688%
-9.17%
-27.3208%
-46.5028%
-65.4661%
-22.4713%
-63.9841%
-91.3333%
-85.9532%
-51.2804%
-47.7736%
-82.0548%
-88.9459%
-80.0807%
-69.1466%
-137.2887%
-153.0103%
-116.7118%
-176.8751%
-330.9816%
-205.9521%
-744.9311%
-262.6167%
-274.6227%
-436.0242%
-2,531.1017%
-602.0676%
-1,195.0828%
-2,080.2897%
-2,091.8665%
0%
0%
0%
0%
0%
0%
1,763.9706%
-5,611.2628%
-2,920%
-3,328.0702%
-3,981.7901%
-36,289.7436%
0%
0%
0%
0%
-83.5386%
-163.0306%
-217.016%
-161.2108%
-301.3366%
-215.6219%
-1,737.5271%
0%
0%
0%
67.9643%
-260.2076%
-243.6672%
-259.1837%
-331.8757%
-244.1007%
-266.8505%
-283.7658%
-738.2287%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.